Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Prebet, Thomas
[Clear All Filters]
2023
Platzbecker U
,
Porta MGiovanni D
,
Santini V
,
Zeidan AM
,
Komrokji RS
,
Shortt J
,
Valcarcel D
,
Jonasova A
,
Dimicoli-Salazar S
,
Tiong ISoo
, et al.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Lancet. 2023.
PubMed
Google Scholar
Ravandi F
,
Döhner H
,
Wei AH
,
Montesinos P
,
Pfeilstöcker M
,
Papayannidis C
,
Lai Y
,
Wang K
,
See WL
,
de Menezes DLopes
, et al.
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Br J Haematol. 2023.
PubMed
Google Scholar
Zeidan AM
,
Pollyea DA
,
Borate U
,
Vasconcelos A
,
Potluri R
,
Rotter D
,
Kiendrebeogo Z
,
Gaugler L
,
Prebet T
,
Strocchia M
, et al.
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Ann Hematol. 2023.
PubMed
Google Scholar
2018
Ball B
,
Komrokji RS
,
Ades L
,
Sekeres MA
,
DeZern AE
,
Pleyer L
,
Vey N
,
Almeida A
,
Germing U
,
Cluzeau T
, et al.
Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.
Blood Adv. 2018;2(16):2063-2071.
PubMed
Google Scholar